Violeta Spaniol
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Microbiology top 10%
- Bacterial Infections and Vaccines
Papers in
-
- Pneumonia and Respiratory Infections 7
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Microscopic Colitis 1
-
- Antimicrobial Resistance in Staphylococcus 3
- Clostridium difficile and Clostridium perfringens research 1
- Co-authors
- Christoph Aebi (10 shared papers)Rolf Troller (7 shared papers)Nadja Heiniger (3 shared papers)Sara Vanessa Bernhard (1 shared paper)André R. Miserez (1 shared paper)Patrick Y Muller (1 shared paper)Mattheus W. Vischer (1 shared paper)André Schaller (2 shared papers)
- Journals
- The Journal of Infectious Diseases (2 papers)BMC Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Supportive Care in Cancer (1 paper)Microbes and Infection (1 paper)
- Partner nations
- SwitzerlandDominican RepublicSweden
In The Last Decade
Violeta Spaniol
13 papers receiving 315 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 79
- Microbiology 57
- Endocrinology 33
- Virology 25
- Applied Microbiology and Biotechnology 9
Countries citing papers authored by Violeta Spaniol
This map shows the geographic impact of Violeta Spaniol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Spaniol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Spaniol more than expected).
Fields of papers citing papers by Violeta Spaniol
This network shows the impact of papers produced by Violeta Spaniol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Spaniol. The network helps show where Violeta Spaniol may publish in the future.
Co-authors
The 22 scholars most cited alongside Violeta Spaniol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 62 | |
| 2 | 2015 | 47 | |
| 3 | 2002 | 43 | |
| 4 | 2007 | 39 | |
| 5 | 2010 | 26 | |
| 6 | 2009 | 22 | |
| 7 | 2010 | 17 | |
| 8 | 2011 | 17 | |
| 9 | 2013 | 17 | |
| 10 | 2012 | 16 | |
| 11 | 2009 | 12 | |
| 12 | 2022 | 8 | |
| 13 | 2020 | 4 |
About Violeta Spaniol
Violeta Spaniol is a scholar working on Epidemiology, Infectious Diseases, Critical Care and Intensive Care Medicine, Molecular Medicine and Endocrinology, having authored 13 papers that have together received 330 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Microscopic Colitis (1 paper), HIV-related health complications and treatments (1 paper), Pediatric health and respiratory diseases (1 paper), Inhalation and Respiratory Drug Delivery (1 paper) and Clostridium difficile and Clostridium perfringens research (1 paper). The work is most often cited by research in Molecular Medicine (79 citations), Microbiology (57 citations), Endocrinology (33 citations), Virology (25 citations) and Applied Microbiology and Biotechnology (9 citations). Violeta Spaniol has collaborated with scholars based in Switzerland, Dominican Republic and Sweden. Frequent co-authors include Christoph Aebi, Rolf Troller, Nadja Heiniger, Sara Vanessa Bernhard, André R. Miserez, Patrick Y Muller, Mattheus W. Vischer, André Schaller, Stefan Wyder and Sonja C. Lüer. Their work appears in journals such as The Journal of Infectious Diseases, BMC Microbiology, Antimicrobial Agents and Chemotherapy, Supportive Care in Cancer and Microbes and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.